RCEL - AVITA Medical Inc Trailing Twelve Months Revenue Growth

AVITA Medical, Inc. (RCEL) generates revenue through the sale of innovative RECELL skin regeneration systems. The company scales its business via contract manufacturing and external distribution. The sector's specific nature ensures resilience against macroeconomic shocks. The rolling annual sales growth trend demonstrates the company's operational dynamics, while the 16.70 metric indicates the current pace of revenue expansion.
avitamedical.com (RCEL) - metric breakdowns and financial figures

A conservative investor utilizes fundamental analysis to identify long-term business development trends while filtering out market noise. The year-over-year product sales volume dynamics for the TTM measure the revenue growth rate over the last twelve months, which for AVITA Medical, Inc. (RCEL) confirms the effectiveness of monopoly pricing power over its unique tissue regeneration technology, establishing a high capitalization potential for the asset.